Stay Ahead of Legal and Regulatory Changes at the 2011 BIO International Convention

BIO International Convention to devote several breakout sessions to the topic of legal counsel within the biotech industry.</p>

WASHINGTON, D.C. (May 25, 2011) — Providing legal counsel within the biotech industry comes with a unique set of challenges.  Legal professionals must consistently stay on top of the latest policy and regulatory changes within the industry. For this reason, several breakout sessions have been devoted to the topic at the upcoming 2011 BIO International Convention. The Convention will take place June 27-30, 2011, in Washington, D.C. at the Walter E. Washington Convention Center, and is expected to attract more than 15,000 industry leaders from around the world.

“We recognize the need for bringing experts in the patenting, policy and licensing field together with attendees to discuss the ever changing and evolving legal requirements within the industry,” said Jim Greenwood, president and CEO of BIO. “We are pleased to offer such a dynamic range of breakout sessions and experts to the biotech legal community.”

From patent issues to new laws on licensing to regulations for new innovations, the BIO International Convention will feature the latest updates, insights and networking opportunities—plus educational sessions offering up to eight CLE credit hours.  Attendees will also be able to connect with other legal professionals and leaders in a variety of events during the Convention: the Tuesday Keynote Luncheon with Tony Blair, the BIO Golf Outing, the Opening Reception at the Newseum, the Licensing Professionals Meetup, and much more. 

Below is an overview of related breakout sessions:

A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars

Monday, June 27, 3:45 pm – 5:00 pm
This session will educate attendees on the requirements of a new biosimilar patent litigation pathway.

The Myriad Case and the Patentability of Isolated DNA Molecules
Tuesday, June 28, 8:30 am – 9:45 am
This panel will discuss high-profile patent cases and address recent developments in the Myriad case and BIO’s leadership role as an amicus.  

Navigating the New Law on Licensing Biosimilars
Tuesday, June 28, 10:00 am – 11:30 am 

This session will explain how the regulatory pathway operates and the legal issues in development and marketing biologics and review how scientific challenges affect regulators and the companies seeking approval for biosimilars.

Talking about Your Product in the New Age: Social Media and the Internet
Tuesday, June 28, 3:45 pm – 5:00 pm

This session will address the current regulatory standards and policies related to dissemination of information through the Internet and social media activities to avoid potential liability.

Collaborative R&D from the Perspective of Large Multinationals, Universities and Start-ups

Wednesday, June 29, 2:00 pm – 3:30 pm
Panelists will teach participants how to approach technology owners and attract sponsors for research and licensing revenues. The session will also address key aspects of collaboration and licensing agreements.

Innovative Collaborations: Deal Structures for Nonprofit/For-Profit Collaborations
Thursday, June 30, 8:30 am – 9:45 am

This session will highlight successful industry collaborations with nonprofits and present structures and terms to avoid in the interest of a successful collaboration.

 Regulatory Issues for Tissue Engineered Products
Thursday, June 30, 10:00 am – 11:30 am

FDA staff will address current FDA thinking on the regulation of tissue engineered products, including good manufacturing practices. An industry representative will identify current industry concerns.

The BIO International Convention is the largest global event for the biotechnology industry, offering networking and partnering opportunities with policymakers, scientists, CEOs and newsmakers, and hundreds of sessions covering biotech trends, policy issues and technological innovations. The Convention also features the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to gather and discuss strategic opportunities. For registration, conference agenda and exhibitor information, visit 2011 BIO International Convention.

Note to Editors: Members of the media can register at


Upcoming BIO Events

Partnering for Global Health Forum 2011

June 27, 2011
Washington, DC

BIO International Convention
June 27-30, 2011
Washington, DC

2011 BIO Human Resources Conference
June 26-28, 2011
Washington, DC

The Business Forum at the BIO International Convention
June 28-30, 2011
Washington, DC

BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India

BIO China International Conference
October 12-13, 2011
Shanghai, China

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

For more information:

  • Visit
  • Follow us on Twitter @IAmBiotech
  • Join us on LinkedIn/MyBio
  • Become a fan at